EMBIO LTD
Overview
EMBIO LTD is an active pharmaceutical ingredient (API) supplier with 4 active FDA Type II Drug Master Files, covering CANNABIDIOL-SYNTHETIC; EPHEDRINE SULFATE USP; PSEUDOEPHEDRINE HYDROCHLORIDE, USP; PSEUDOEPHEDRINE SULFATE USP.
API / Drug Master Files
EMBIO LTD holds 4 active (6 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- CANNABIDIOL-SYNTHETICActive2023-05-11
- PSEUDOEPHEDRINE SULFATE USPActive2021-05-23
- EPHEDRINE SULFATE USPActive2018-04-17
- PSEUDOEPHEDRINE HYDROCHLORIDE, USPActive1998-12-29
- PSEUDOEPHEDRINE SULFATE USPInactive2000-01-31
- EPHEDRINE HYDROCHLORIDE USPInactive1991-08-09
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to EMBIO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.